Importantly, HPV-specific CD8+ T cell responses and their clonotypic composition were comparable in patient-matched primary tumor and metastatic lymph node samples, suggesting that different HPV+ HNSCC tumor sites exhibit similar immune environments and immune pressure [78]. This evidence concerns the gene CD8A and neoplasm.